Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 6 studies | 24% ± 6% | |
| fibroblast | 4 studies | 26% ± 8% | |
| smooth muscle cell | 3 studies | 24% ± 5% |
Insufficient scRNA-seq data for expression of CALHM2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 3812.04 | 459 / 459 | 100% | 33.10 | 1115 / 1118 |
| ovary | 100% | 4328.89 | 180 / 180 | 99% | 41.04 | 427 / 430 |
| thymus | 99% | 2194.25 | 649 / 653 | 98% | 14.17 | 591 / 605 |
| bladder | 100% | 3178.19 | 21 / 21 | 97% | 17.66 | 489 / 504 |
| lung | 100% | 2298.28 | 577 / 578 | 96% | 15.36 | 1109 / 1155 |
| uterus | 100% | 5786.11 | 170 / 170 | 95% | 20.36 | 437 / 459 |
| prostate | 99% | 2082.90 | 243 / 245 | 95% | 11.99 | 478 / 502 |
| skin | 98% | 1917.89 | 1764 / 1809 | 96% | 21.03 | 452 / 472 |
| adrenal gland | 97% | 1664.07 | 250 / 258 | 94% | 28.22 | 216 / 230 |
| esophagus | 97% | 2056.86 | 1396 / 1445 | 93% | 11.60 | 170 / 183 |
| intestine | 98% | 1711.47 | 950 / 966 | 88% | 11.79 | 462 / 527 |
| stomach | 75% | 1035.99 | 269 / 359 | 85% | 11.69 | 242 / 286 |
| kidney | 70% | 725.04 | 62 / 89 | 80% | 14.36 | 718 / 901 |
| pancreas | 30% | 198.30 | 97 / 328 | 99% | 25.14 | 176 / 178 |
| brain | 27% | 169.01 | 721 / 2642 | 98% | 13.12 | 692 / 705 |
| adipose | 100% | 4610.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.64 | 29 / 29 |
| spleen | 100% | 3270.01 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 17.64 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.65 | 1 / 1 |
| blood vessel | 100% | 3778.65 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 1704.97 | 845 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 91% | 1399.53 | 841 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 75% | 12.60 | 60 / 80 |
| liver | 8% | 55.44 | 17 / 226 | 48% | 5.08 | 195 / 406 |
| muscle | 52% | 390.75 | 418 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1903978 | Biological process | regulation of microglial cell activation |
| GO_0070509 | Biological process | calcium ion import |
| GO_0048167 | Biological process | regulation of synaptic plasticity |
| GO_0098655 | Biological process | monoatomic cation transmembrane transport |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_1904669 | Biological process | ATP export |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005261 | Molecular function | monoatomic cation channel activity |
| Gene name | CALHM2 |
| Protein name | Calcium homeostasis modulator protein 2 (Protein FAM26B) |
| Synonyms | FAM26B |
| Description | FUNCTION: Pore-forming subunit of a voltage-gated ion channel. . |
| Accessions | Q9HA72 ENST00000369788.7 [Q9HA72-1] ENST00000260743.10 [Q9HA72-1] |